
Deoson Pharmaceutical Private Limited
About Deoson Pharmaceutical Private Limited
Data last updated:
Deoson Pharmaceutical Private Limited is a private limited company based in Bhojpur, Bihar, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24299BR2021PTC053967.
The company has an authorised share capital of ₹1.2 Lakh and a paid-up capital of ₹1.2 Lakh. It is led by directors Anupam Kumar and Arun Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Amrendra Kumar S/O Dev Kr Village – Deoria Deoria Panch – Piania Block – Udwant Nagar, Bhojpur, Bihar, India – 802210.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.79 Lakh, a growth of 36% compared to the previous year. For the same year it recorded a net loss of ₹1.14 Lakh (net margin -7.7%) and EBITDA of -₹1.07 Lakh (EBITDA margin -7.3%). Revenue has grown at a compounded annual rate (CAGR) of 554% over three years.
Deoson Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-08-0003465).
Company details
Recognitions & Rankings of Deoson Pharmaceutical
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-BR-08-0003465
Contact details
Deoson Pharmaceutical Private Limited's registered office is in Bhojpur, Bihar.
- Registered AddressAmrendra Kumar S/O Dev Kr Village – Deoria Deoria Panch – Piania Block – Udwant Nagar, Bhojpur, Bihar, India – 802210
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Deoson Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Deoson Pharmaceutical Private Limited, buy the company report.
Financials of Deoson Pharmaceutical Private Limited
FY 2025 filings availableDeoson Pharmaceutical Private Limited reported revenue of ₹14.79 Lakh (up 36% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 554% over three years, including 36% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹1.07 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1.14 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -7.3% | |||
| Net Profit Margin | -7.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Deoson Pharmaceutical Private Limited, buy the company report.
Board of directors of Deoson Pharmaceutical Private Limited
Deoson Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anupam Kumar | Director | 10 Sep 2021 | 5 Years 2 Months | Current |
| Arun Kumar | Director | 10 Sep 2021 | 5 Years 2 Months | Current |
Peer comparison
Deoson Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale and retail trade and repair of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| World Infra Solution Private Limited | ₹14.99 Lakh (FY 2025) | -80.0% | Jodhpur, Rajasthan, India | |||
| Morex Penetration Private Limited | ₹14.91 Lakh (FY 2025) | -49.0% | Mumbai, Maharashtra, India | |||
| Narayan Lifesciences Private Limited | ₹14.89 Lakh (FY 2024) | 147.0% | Visakhapatnam, Andhra Pradesh, India | |||
| Yabez International Private Limited | ₹14.83 Lakh (FY 2025) | 377.0% | Aurangabad, Maharashtra, India | |||
| S B Vyapaar Pvt Ltd | ₹14.82 Lakh (FY 2025) | 1.0% | Kolkata, West Bengal, India | |||
| Deoson Pharmaceutical Private Limitedthis company | ₹14.79 Lakh (FY 2025) | -₹1.14 Lakh | -7.7% | 36.0% | Bhojpur, Bihar, India | |
| GDNS Project Private Limited | ₹14.79 Lakh (FY 2025) | 291.0% | Bangalore, Karnataka, India | |||
| R K N Industries Private Limited | ₹14.79 Lakh (FY 2025) | 224.0% | Neemrana, Rajasthan, India | |||
| Tershivar Agro Farmer Producer Company Limited | ₹14.75 Lakh (FY 2025) | 21.0% | Osmanabad, Maharashtra, India | |||
| Walbro Overseas Private Limited | ₹14.73 Lakh (FY 2024) | -47.0% | Mumbai, Maharashtra, India | |||
| Jawad Sfac Women Farmer Producer Company Limited | ₹14.65 Lakh (FY 2023) | 363.0% | Jawad, Madhya Pradesh, India |
To see the full peer comparison of Deoson Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Deoson Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Deoson Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Deoson Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Deoson Pharmaceutical Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Anupam Kumar was appointed as Director on 10 Sep 2021.
Frequently asked questions
Deoson Pharmaceutical is an active private limited company based in Bhojpur, Bihar, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 September 2021 (5+ years old) and is registered under CIN U24299BR2021PTC053967.
Deoson Pharmaceutical has 2 current directors:
- Anupam Kumar - Director
- Arun Kumar - Director
The latest financial statements of Deoson Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Deoson Pharmaceutical is U24299BR2021PTC053967. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Deoson Pharmaceutical was incorporated on 10 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Deoson Pharmaceutical by revenue are World Infra Solution Private Limited, Morex Penetration Private Limited, Narayan Lifesciences Private Limited, Yabez International Private Limited, S B Vyapaar Pvt Ltd and 5 more, all in the same principal business activity (wholesale and retail trade and repair of motor vehicles and motorcycles).
Anupam Kumar was appointed as Director on 10 Sep 2021. Arun Kumar was appointed as Director on 10 Sep 2021.
Yes, Deoson Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Deoson Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-08-0003465).
The registered office of Deoson Pharmaceutical is at Amrendra Kumar SO Dev Kr Village – Deoria Deoria Panch – Piania Block – Udwant Nagar, Bhojpur, Bihar, India – 802210.
Deoson Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

